"Hepatitis B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Descriptor ID |
D006509
|
| MeSH Number(s) |
C02.256.430.400 C02.440.435 C06.552.380.705.437
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B".
This graph shows the total number of publications written about "Hepatitis B" by people in this website by year, and whether "Hepatitis B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 3 | 4 |
| 1995 | 2 | 2 | 4 |
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 1 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 2 | 4 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 4 | 2 | 6 |
| 2007 | 5 | 2 | 7 |
| 2008 | 4 | 5 | 9 |
| 2009 | 4 | 3 | 7 |
| 2010 | 7 | 1 | 8 |
| 2011 | 4 | 0 | 4 |
| 2012 | 9 | 3 | 12 |
| 2013 | 6 | 2 | 8 |
| 2014 | 3 | 0 | 3 |
| 2015 | 9 | 1 | 10 |
| 2016 | 2 | 2 | 4 |
| 2017 | 3 | 2 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 3 | 2 | 5 |
| 2020 | 3 | 1 | 4 |
| 2021 | 6 | 1 | 7 |
| 2022 | 6 | 0 | 6 |
| 2023 | 7 | 0 | 7 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B" by people in Profiles.
-
Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma. Lancet. 2024 Apr 06; 403(10434):1372-1373.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
-
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023 Dec; 20(12):864-884.
-
Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination. Trans R Soc Trop Med Hyg. 2023 09 01; 117(9):628-636.
-
HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. Front Immunol. 2023; 14:1216610.
-
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients. J Natl Cancer Inst. 2023 06 08; 115(6):703-711.
-
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
-
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors. Clin Lymphoma Myeloma Leuk. 2023 08; 23(8):610-615.
-
False-reactive hepatitis B surface antigen test results in cancer patients. Eur J Clin Microbiol Infect Dis. 2023 03; 42(3):383-385.
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.